节点文献

CYP2D6表现型决定16名中国汉族受试者普罗帕酮对映体药物动力学的差异<英文>

CYP2D6 phenotype determines pharmacokinetic variability of propafenone enantiomers in 16 HAN Chinese subjects

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 蔡卫民陈冰蔡明虹张银娣

【Author】 CAI Wei-Min, CHEN Bing, CAI Ming-Hong, ZHANG Yin-Di(Institute of Clinical Pharmacology, Nanjing Medical University; Department of Clinical Pharmacology,Nanjing General Hospital of Nanjing Command, Nanjing 210002 , China)

【机构】 南京医科大学临床药理研究所南京军区南京总医院临床药理科南京医科大学临床药理研究所 南京 中国 210002南京 中国 210002

【摘要】 目的:研究CYP2D6表现型在汉族健康受试者普罗帕酮对映体代谢中的作用。方法:选取用右美沙芬进行代谢分型后得到的7名极快代谢者(VEM)和9名中速代谢者(IM)。单剂量口服消旋普罗帕酮400mg,抽取0-15h静脉血。运用反相高压液相色谱法加柱前衍生化,定量分析血浆中普罗帕酮对映体浓度。结果:两种CYP2D6表现型的S-Pro代谢均较R-Pro慢,血浆浓度升高。此外,IM中R-Pro的半衰期比R-Pro大,VEM无此差别。但是,Pro对映体在VEM和IM中的代谢有明显差异。IM组两种对映体的Cmax和AUC均比VEM组大(P<0.05)。IM组Pro对映体的Cl仅为VEM组的一半[(67±17)vs(133±28)L·h-1for S-Pro,(90±24)vs(200±87)L·h-1for R-Pro,P<0.0]。T1/2,Tmax,Cmax,Cl和AUC的S/R比值无显著差异(P>0.05)。结论:CYP2D6表现型决定了普罗帕酮对映体的药动学差异,EM受试者中IM的存在也许与中国人CYP2D6酶活性下降有关。

【Abstract】 AIM: To determine the role of the CYP2D6 phenotype in the metabolism of propafenone (Pro) enantiomers in 16 HAN Chinese subjects. METHODS: Seven very extensive metabolizers (VEM) and nine intermediate metabolizers ( IM) were enrolled from a Chinese population whose phenotype had been previously assessed with a dextromethorphan metabolic phenotyp-ing. The blood samples (0 - 15 h) were taken after oral administration of a single dose (400 mg) of rac-Pro hydrochloride. Enantiomeric concentrations of propafenone in plasma were measured by a reverse-phase HPLC with precolumn derivatization. RESULTS: S-Pro was less metabolized and had higher plasma concentrations than R-Pro in both CYP2D6 phenotypes. Besides, the T1/2 of R-Pro was longer than that of S-Pro in IM, but not in VEM. However, there were significant differences in the metabolism of Pro enantiomers between VEM and IM. The Cmax and AUC of both isomers in the IM group were higher than those in the VEM group (P < 0.01). The Cl of Pro enantiomers in IM group was only about half of that in VEM group [(67 ±17) vs (133±28) L·h-1 for S-Pro, (90±24) vs (200±87) L·h-1 for R-Pro, P<0.01]. The S/R ratios of T1/2, Tmax, Cmax, Cl, and AUC were not significantly different ( P > 0.05). CONCLUSION: CYP2D6 phenotype determines the pharmacokinetic variability of propafenone enantiomers and existence of IM may be relevant to diminished capacity of CYP2D6 enzyme in Chinese subjects.

【基金】 Project supported by the Army Medical Research Foundation of PLA, China (Grant № 96M023);by Research Finacial Aid for Overseas Scholar from the Ministry of Human Resources,China (Grant № 96HG01).
  • 【文献出处】 Acta Pharmacologica Sinica ,中国药理学报(英文版) , 编辑部邮箱 ,1999年08期
  • 【分类号】R96
  • 【被引频次】1
  • 【下载频次】8
节点文献中: 

本文链接的文献网络图示:

本文的引文网络